This week the spotlight has been cast on India covid cases spiralling, with a new local variant also adding to concerns. While on paper selling INR seems a straightforward expression of the risks involved, there are complications to note in this case. Still, economists at Credit Suisse can envisage a scenario that sees USD/INR push to test its all-time high seen last year at 76.72 in coming weeks.
Covid risks multiply but RBI complicates the FX picture
“For a variety of reasons including religious festivals, political rallies, relatively low vaccine take-up (despite the country being a major producer) and government reticence to impose lockdowns ahead of state elections, daily covid infection rates are spiralling, with a new local variant also adding to concerns.”
“While on paper selling INR seems a straightforward expression of the risks involved, there are complications to note in this case. Firstly, being short INR has a clear negative carry problem, with 1m NDF implied INR rates around 6%. Secondly, the RBI is in a powerful position to resist excessive INR depreciation. With $542bio of total reserves as of Dec 2020, and having added still more in the early months of 2021, the RBI is in a strong position to try to limit INR weakness.”
“The fact it has already allowed spot INR to fall 3% in April vs USD despite general USD weakness elsewhere suggests the central bank might yet be willing to tolerate more INR losses, and we can envisage a scenario that sees USD/INR push to test its all-time high seen last year at 76.72 in coming weeks.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD hovers around 0.6500 amid light trading, ahead of US GDP
AUD/USD is trading close to 0.6500 in Asian trading on Thursday, lacking a clear directional impetus amid an Anzac Day holiday in Australia. Meanwhile, traders stay cautious due ti risk-aversion and ahead of the key US Q1 GDP release.
USD/JPY finds its highest bids since 1990, near 155.50
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, testing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming Japanese intervention risks. Focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold price lacks firm intraday direction, holds steady above $2,300 ahead of US data
Gold price remains confined in a narrow band for the second straight day on Thursday. Reduced Fed rate cut bets and a positive risk tone cap the upside for the commodity. Traders now await key US macro data before positioning for the near-term trajectory.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price. Coupled with broader market gloom, INJ token’s doomed days may not be over yet.
Meta Platforms Earnings: META sinks 10% on lower Q2 revenue guidance Premium
This must be "opposites" week. While Doppelganger Tesla rode horrible misses on Tuesday to a double-digit rally, Meta Platforms produced impressive beats above Wall Street consensus after the close on Wednesday, only to watch the share price collapse by nearly 10%.